
Sign up to save your podcasts
Or


Host: Darryl S. Chutka, M.D.
Guest: Eric J. Moore, M.D.
Salivary gland tumors can be benign or malignant, as well as primary or metastatic. Malignant salivary gland tumors usually present after the 6th decade, whereas benign lesions tend to occur a bit earlier, usually in the 4th to 5th decades. An interesting statistic is that the vast majority of salivary gland tumors occur in the parotid, only about 10% occur in the submandibular salivary gland and less than 4% in the minor salivary glands. Fortunately, most parotid tumors are benign. Previous radiation as well as occupational exposure to silica and nitrosamines have been linked to malignant parotid tumors. What should a primary care clinician do when we discover a mass in the parotid gland? What imaging studies are helpful? What treatment is available and what happens if the tumor recurs? These are all questions I’ll be asking my guest, Eric J. Moore, M.D., Chair of Otolaryngology and Head and Neck Surgery at the Mayo Clinic as we discuss “Parotid Gland Tumors”.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts
By Mayo Clinic4.4
268268 ratings
Host: Darryl S. Chutka, M.D.
Guest: Eric J. Moore, M.D.
Salivary gland tumors can be benign or malignant, as well as primary or metastatic. Malignant salivary gland tumors usually present after the 6th decade, whereas benign lesions tend to occur a bit earlier, usually in the 4th to 5th decades. An interesting statistic is that the vast majority of salivary gland tumors occur in the parotid, only about 10% occur in the submandibular salivary gland and less than 4% in the minor salivary glands. Fortunately, most parotid tumors are benign. Previous radiation as well as occupational exposure to silica and nitrosamines have been linked to malignant parotid tumors. What should a primary care clinician do when we discover a mass in the parotid gland? What imaging studies are helpful? What treatment is available and what happens if the tumor recurs? These are all questions I’ll be asking my guest, Eric J. Moore, M.D., Chair of Otolaryngology and Head and Neck Surgery at the Mayo Clinic as we discuss “Parotid Gland Tumors”.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

135 Listeners

318 Listeners

697 Listeners

497 Listeners

260 Listeners

263 Listeners

3,339 Listeners

1,156 Listeners

195 Listeners

85 Listeners

512 Listeners

364 Listeners

12 Listeners

248 Listeners

18 Listeners

15 Listeners

9 Listeners

430 Listeners

369 Listeners

45 Listeners

14 Listeners